Infrastructure
Healthcare providers may want to launch infusion services without building their own sterile preparation infrastructure.
The problem
Infusion care is fragmented between prescription, preparation, delivery and administration.
Operations
Clinical workflows are fragmented across ordering, pharmacy verification, preparation, delivery, administration and documentation.
Scale
Opening additional provider sites traditionally creates operational complexity and duplicated infrastructure.
The opportunity is not simply to prepare an infusion. It is to build the infrastructure that allows infusion care to scale.
The model
One operating layer. Many provider sites.
Physician order
Pharmacy verification
Patient-specific preparation
Controlled logistics
Provider site
Administration
Documentation
Central Infusion Hub
Provider A
Provider B
Provider C
Provider D
Infusion combines preparation infrastructure, provider enablement and digital workflow into a repeatable B2B operating model.
Real-world validation
Validated with real patients and paying healthcare providers.
131
Documented preparations
SAR 84.3K
Documented revenue
5
Paying healthcare organizations
SAR 600
Actual B2B ASP
Patient validation
82 treatments · 46 unique patients · 17 repeat patients
SAR 54.9K documented patient-side revenue
B2B validation
5 healthcare organizations · 49 preparations
SAR 29.4K documented B2B sales · SAR 600 actual ASP
Historical proof-of-concept data from the initial healthcare-site implementation.
Unit economics
Designed to create value on both sides of the transaction.
Infusion
SAR 600
B2B revenue / preparation
- Estimated variable cost
- ~SAR 213
- Contribution / preparation
- ~SAR 387
- Estimated contribution margin
- ~64.5%
Healthcare provider
~SAR 1,500
Average patient selling price
- Infusion B2B cost
- SAR 600
- Gross spread before provider administration cost
- ~SAR 900
Drug + material COGS based on available BOM/procurement data. Preparation/QA and logistics costs are management estimates. Provider pricing is an observed/management market benchmark and may vary by provider.
The platform
The digital operating layer is already built.
Personalized care plan
Patient-specific formulation and treatment planning.
Controlled clinical workflow
Order → Verify → Prepare → Administer → Complete.
Role-based accountability
Physician → Clinical Pharmacist → Infusion Nurse.
Pharmacy governanceOperational visibilityClinical safetyAuditability
Functional MVP · Demo environment · Representative synthetic patient data
Why Saudi · Why now
A healthcare system ready for distributed infusion infrastructure.
Large healthcare provider footprint
Expanding private healthcare delivery
Existing home-healthcare infrastructure
Growing specialty-care requirements
Healthcare transformation
Private-sector participation
Infusion is being built in Saudi Arabia first, with a model designed for replication across the GCC.
Scaling infrastructure
Prove one hub. Densify the network. Replicate the model.
01
Prove
Riyadh
One hub → private B2B providers
02
Densify
Riyadh
One hub → multiple provider branches
03
Replicate
Saudi Arabia
Riyadh → Jeddah → Eastern Province
04
Expand
GCC
Replicate the operating infrastructure in selected markets
Expansion locations represent the planned scaling model and are not presented as current operations.
MA
Founder · Riyadh
Founder
Healthcare operating experience behind the infrastructure.
Dr. Mohamed Azzam
Founder & CEO
Healthcare executive and entrepreneur with experience in healthcare operations, oncology services, provider development, quality, strategy and business transformation in Saudi Arabia and the GCC.
Investment
Funding the proof. Scaling after the economics are proven.
Interested in the infrastructure layer for personalized, distributed infusion care?
Focus of the current stage
Funding is directed to the launch and validation of the first scalable Infusion operating hub in Riyadh.
Priority areas
Technology & platformCore operating teamWorking capitalCommercial launchLogisticsRegulatory / QA infrastructure
Round details are shared privately with qualified investors.